Ectodysplasin A (EDA) Signaling: From Skin Appendage to Multiple Diseases

    Ruihan Yang, Yilan Mei, Ye Jiang, Huiling Li, Ruixi Zhao, Jian Sima, Yuyuan Yao
    Image
    Studysummary This review summarizes the role of Ectodysplasin A signaling in skin appendage development and various diseases, noting potential clinical applications but reporting no new research findings.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document discusses the role of Ectodysplasin A (EDA) signaling in various diseases. EDA signaling, initially identified as a regulator of skin appendage formation, is implicated in hypohidrotic ectodermal dysplasia (HED), various types of cancer, and nonalcoholic fatty liver disease (NAFLD). Mutations in EDA can cause HED, a congenital hereditary disease characterized by malformation of skin appendages. In cancer, EDA and its receptors can influence cell proliferation, apoptosis, differentiation, and migration, potentially affecting tumorigenesis and cancer progression. EDA signaling has also been implicated in the pathogenesis of NAFLD and type II diabetes by regulating glucose and lipid metabolism. The document concludes by highlighting the need for further studies on the molecular mechanism and distinct roles of EDA signaling in numerous diseases.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results